Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AB1 | P08238 | 11/20 | 0.57 |
| ▸ | HSP90AA1 | P07900 | 10/20 | 0.57 |
| ▸ | ERBB2 | P04626 | 7/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | HSP90B1 | P14625 | 1/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.35 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1967170 | 0.89 | HSP90AB1 (0.73) | HSP90AB1HSP90AA1ERBB2HSP90B1 | |
| SCHEMBL5416164 | 0.83 | HSP90AB1 (0.51) | HSP90AB1HSP90AA1ERBB2LMNATP53 | |
| SCHEMBL14466177 | 0.79 | HSP90AA1 (0.59) | HSP90AB1HSP90AA1ERBB2HSP90B1 | |
| SCHEMBL1965605 | 0.79 | ERBB2 (0.73) | HSP90AB1HSP90AA1ERBB2 | |
| SCHEMBL1963778 | 0.79 | HSP90AB1 (0.73) | HSP90AB1HSP90AA1ERBB2 | |
| SCHEMBL1964104 | 0.79 | ERBB2 (0.73) | HSP90AB1HSP90AA1ERBB2HSP90B1 | |
| SCHEMBL1964988 | 0.75 | HSP90AA1 (0.78) | HSP90AB1HSP90AA1ERBB2 | |
| SCHEMBL1964201 | 0.73 | HSP90AA1 (1.00) | HSP90AB1HSP90AA1ERBB2HSP90B1 | |
| SCHEMBL30583202 | 0.73 | HSP90AA1 (1.00) | HSP90AB1HSP90AA1ERBB2HSP90B1 | |
| SCHEMBL1966909 | 0.72 | HSP90AB1 (0.80) | HSP90AB1HSP90AA1ERBB2HSP90B1ADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1962863-A2 | ORALLY ACTIVE PURINE-BASED INHIBITORS OF HEAT SHOCK PROTEIN 90 | Conforma Therapeutics Corporation (US) | 2008-09-03 | — | — | EP | disclosed |
| WO-2007075572-A2 | ORALLY ACTIVE PURINE-BASED INHIBITORS OF HEAT SHOCK PROTEIN 90 | CONFORMA THERAPEUTICS CORPORATION (US) | 2007-07-05 | — | — | WO | disclosed |